Cargando…
Reconstruction of intestinal microecology of type 2 diabetes by fecal microbiota transplantation: Why and how
Type 2 diabetes (T2D) is a chronic metabolic disease characterized by hyperglycemia due to insulin resistance. Mounting evidence has correlated T2D to alterations in the composition of gut microbiota. Accordingly, targeting the gut microbiota has become an emerging strategy for T2D management. The a...
Autores principales: | Hou, Kaijian, Zhang, Shuo, Wu, Zezhen, Zhu, Dan, Chen, Fengwu, Lei, Zi-Ning, Liu, Weiting, Xiao, Chuanxing, Chen, Zhe-Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9162745/ https://www.ncbi.nlm.nih.gov/pubmed/34761734 http://dx.doi.org/10.17305/bjbms.2021.6323 |
Ejemplares similares
-
Fecal microbiota transplantation treatment of autoimmune-mediated type 1 diabetes mellitus
por: He, Lina, et al.
Publicado: (2022) -
Fecal microbiota transplantation treatment of autoimmune-mediated type 1 diabetes: A systematic review
por: Zhang, Shuo, et al.
Publicado: (2022) -
Fecal microbiota transplantation reverses insulin resistance in type 2 diabetes: A randomized, controlled, prospective study
por: Wu, Zezhen, et al.
Publicado: (2023) -
Polyethylene Glycol Loxenatide Injection (GLP-1) Protects Vascular Endothelial Cell Function in Middle-Aged and Elderly Patients With Type 2 Diabetes by Regulating Gut Microbiota
por: Chen, Fengwu, et al.
Publicado: (2022) -
Pharmacoeconomic analysis (CER) of Dulaglutide and Liraglutide in the treatment of patients with type 2 diabetes
por: Su, Yu, et al.
Publicado: (2023)